PMID: 7016924Apr 1, 1981Paper

Observations on 10 years' HBs antigenaemia after renal transplantation

Journal of Clinical Pathology
J Nagington

Abstract

A renal transplant patient became a carrier of HBs Ag within four weeks of a successful transplant. The level of antigenaemia was extremely high, and approximately 3% of the particles were 42 nm Dane particles, although the anti-HBe was present from at least 20 months after transplant. After four years the antigenaemia declined to a low level, and five years later HBs Ag became undetectable for the first time. During the past 18 months, no antigen has been detected although immunosuppression continues and the original kidney is still functional.

Citations

Jan 1, 1984·Journal of Medical Virology·J NagingtonB J Cohen
May 1, 1983·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G DusheikoM C Kew

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.